neutral soft margin develop evid result
thu increas oper cost forecast also incorpor acquisit
relat integr cost part ordinari oper cost
updat fx assumpt reflect current market rate
sale declin averag respect adj ep declin
roll forward dcf
month retain longer term growth margin assumpt larg
unchang consequ target price goe
absorb increas cost base underli sale growth cse
group ebit margin cse
y/i report result came expect transform
acquisit scican micro-mega contribut cse
pre inventori step-up cost ebit translat satisfactori
margin adjust inventori step-up cost
calcul margin legaci colten busi
y/i manag attribut pressur acquisit relat
integr cost well increas invest system life
cycl manag softwar tool regulatori affair earn call
manag stop short quantifi non-recur cost element
state cost also impact cost base
catalyst risk ceo martin schaufelberg cs mid cap
confer zurich novemb result march risk relat
integr recent acquisit scican/micro-mega
valuat get target price use dcf methodolog
assum averag sale growth adj ebit margin
line manag mid-term target base ep colten
stock trade forward price-to-earnings slightli
year averag
valuat metric
number share
price month
price rel chart measur perform
swiss market ind close
spot exchang rate
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
colten hold ag switzerland base compani
special dental consum small equip cover
whole dental treatment process work develop
manufactur high-precis impress materi fill
price aug rate neutral target price analyst christoph gretler
profit tax
associ
chang work capit
cash non-cash item
flow oper
free cash-flow firm
flow invest
issuanc retir debt
cash-flow financ
chang net cash/debt
scenario assum averag underli
sale growth goe current assumpt
period compani manag consist gain
grey scenario assum averag underli
sale growth would declin compani due lack
scale consist underperform relev market
price rel chart measur perform swiss market
ind close
spot exchang rate
net debt start
chang net debt
net debt end
total equiti liabil
share wtd average mn
ratio valuat
net debt ebitda
result updat fx current market rate sfr/eu
sfr/u incorpor previous separ
acquisit integr cost part ordinari oper cost sale
declin averag adj ep declin averag lower
dkr million unless otherwis state
sale
ebit
base ep colten stock trade forward price-to-earnings slightli
averag toward low end dental industri
target
get target price use dcf methodolog assum averag
sale growth adj ebit margin line manag mid-
sfr million unless otherwis state
tax adj ebit
chang work capit wc
chang asset
invest acquist intang
equiti valu per share sfr
oper wc sale
increment capital-expenditure sale
weight averag cost capit
sfr million unless otherwis state
sale growth local currenc
sale growth sfr
rest world
sfr million unless otherwis state
sale
averag employe
averag wage
sale
sale
gross invest fix asset
depreci
sale
gross fix asset
invest intang
amort acquir intang
amort intang
amort intang
currenc gain loss
compani mention price
